Dr. Bruce Dalkin
M
I've won the following awards
Top Doctor, Seattle Magazine
Best Doctor, Best Doctors in America
Best Doctor, Best Doctors in America
Best Doctor, Best Doctors in America
Listed, Best Doctors in America
Excellence in Teaching in the Clinical Sciences Award, University of Arizona College of Medicine
Clinical Sciences Educator of the Year Award, University of Arizona College of Medicine
Clinical Sciences Educator of the Year Award, University of Arizona College of Medicine
Excellence in Teaching in The Clinical Science Award, University of Arizona College of Medicine
Excellence in Teaching in The Clinical Science Award, University of University of Arizona, College of Medicine
I've published
Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer.
Prostate., Aug (2012)
Editorial comment. Comprehensive quality-of-life outcomes in the setting of a multidisciplinary, equal access prostate cancer clinic.
Urology., Nov;76(5):1238; author reply 1238-9 (2010)
Positive surgical margins at radical prostatectomy predict prostate cancer specific mortality.
J. Urol., Jun;183(6):2213-8 (2010)
Potent men undergoing radical prostatectomy: a prospective study measuring sexual health outcomes and the impact of erectile dysfunction treatments.
Urol. Oncol., 26(3):281-5 (2008 May-Jun)
The failure of a nerve sparing template to improve urinary continence after radical prostatectomy: attention to study design.
Urol. Oncol., 27(4):358-62 (2009 Jul-Aug)
Preservation of penile length after radical prostatectomy: early intervention with a vacuum erection device.
Int. J. Impot. Res., 19(5):501-4 (2007 Sep-Oct)
Re: potency following robotic radical prostatectomy: a questionnaire based analysis of outcomes after conventional nerve sparing and prostatic fascia sparing techniques.
J. Urol., Jun;175(6):2367 author reply 2367-8 (2006)
Health related quality of life outcomes after radical prostatectomy: attention to study design and the patient-based importance of single-surgeon studies.
Urol. Oncol., 24(1):28-32 (2006 Jan-Feb)
Re: Health related quality of life before and after laparoscopic radical prostatectomy.
J. Urol., Jul;174(1):399; author reply 399-400 (2005)
Coccidioidomycosis of the prostate: a determination of incidence, report of 4 cases, and treatment recommendations.
J. Infect., Jan;52(1):e19-25 (2006)
Selenium and selenomethionine levels in prostate cancer patients.
Cancer Detect. Prev., 28(1):8-16 (2004)
Accuracy of prostate needle biopsy in predicting extracapsular tumor extension at radical retropubic prostatectomy: application in selecting patients for nerve-sparing surgery.
Urology., Nov;52(5):814-8; discussion 818-9 (1998)
Prostatic asymmetry as a risk factor for prostatic carcinoma: serial prostate-specific antigen monitoring and cancer detection.
Br J Urol., Jun;79(6):924-6 (1997)
Ketoconazole-induced adrenal crisis in a patient with metastatic prostatic adenocarcinoma: case report and review of the literature.
Urology., May;49(5):781-5 (1997)
Prospective longitudinal evaluation of men with initial prostate specific antigen levels of 4.0 ng./ml. or less.
J. Urol., May;157(5):1740-3 (1997)
Derivation and application of upper limits for prostate specific antigen in men aged 50-74 years with no clinical evidence of prostatic carcinoma.
Br J Urol., Sep;76(3):346-50 (1995)
Dithiothreitol effects on human sperm quality.
J. Urol., Dec;152(6 Pt 2):2287-90 (1994)
Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: receiver operating characteristic curves.
J. Urol., Dec;152(6 Pt 1):2037-42 (1994)
Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves.
J. Urol., Dec;152(6 Pt 1):2031-6 (1994)
Accuracy of digital rectal examination and transrectal ultrasonography in localizing prostate cancer.
J. Urol., Nov;152(5 Pt 1):1506-9 (1994)